High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases.
Jensen, ET; Aceves, SS; Bonis, PA; Bray, K; Book, W; Chehade, M; Collins, MH; Dellon, ES; Falk, GW; Gonsalves, N; et al.
Journal of Pediatric Gastroenterology and Nutrition.
2020;
71:524-529.
Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.
Slack, IF; Schwartz, JT; Mukkada, VA; Hottinger, S; Abonia, JP.
Current Allergy and Asthma Reports.
2020;
20.
Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.
Azouz, NP; Klingler, AM; Pathre, P; Besse, JA; Ben Baruch-Morgenstern, N; Ballaban, AY; Osswald, GA; Brusilovsky, M; Habel, JE; Caldwell, JM; et al.
Science Translational Medicine.
2020;
12:eaaz7773-eaaz7773.
Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms.
Collins, MH; Martin, LJ; Wen, T; Abonia, JP; Putnam, PE; Mukkada, VA; Rothenberg, ME.
Journal of Pediatric Gastroenterology and Nutrition.
2020;
70:598-603.
Monitoring Eosinophilic Esophagitis Disease Activity With Blood Eosinophil Progenitor Levels.
Henderson, A; Magier, A; Schwartz, JT; Martin, LJ; Collins, MH; Putnam, PE; Mukkada, VA; Abonia, JP; Rothenberg, ME; Fulkerson, PC.
Journal of Pediatric Gastroenterology and Nutrition.
2020;
70:482-488.
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.
Shoda, T; Wen, T; Caldwell, JM; Collins, MH; Besse, JA; Osswald, GA; Abonia, JP; Arva, NC; MDd, DA; Capocelli, KE; et al.
Journal of Allergy and Clinical Immunology.
2020;
145:255-269.
Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).
Aceves, S; Collins, MH; Rothenberg, ME; Furuta, GT; Gonsalves, N; Abonia, JP; Almonte, S; Andrews, R; Arrington, A; Arva, N; et al.
Journal of Allergy and Clinical Immunology.
2020;
145:28-37.
Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.
Kottyan, LC; Maddox, A; Braxton, JR; Stucke, EM; Mukkada, V; Putnam, PE; Abonia, JP; Chehade, M; Wood, RA; Pesek, RD; et al.
Genes and Immunity.
2019;
20:281-292.
Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration Why Was the Consortium of Eosinophilic Gastrointestinal Disease Researchers Established?.
Gupta, SK; Falk, GW; Aceves, SS; Chehade, M; Collins, MH; Dellon, ES; Gonsalves, N; Hirano, I; Mukkuda, VA; Peterson, KA; et al.
Gastroenterology.
2019;
156:838-842.
Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care.
Hiremath, G; Kodroff, E; Strobel, MJ; Scott, M; Book, W; Reidy, C; Kyle, S; Mack, D; Sable, K; Abonia, P; et al.
Clinics and Research in Hepatology and Gastroenterology.
2018;
42:483-493.